✦ LIBER ✦

A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia

✍ Scribed by M. Talpaz; R. Kurzrock; H. Kantarjian; J. Rothberg; S. Saks; L. Evans; J. U. Gutterman

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 549 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19911115)68:10<2125::aid-cncr2820681006>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemolytic-Uremic syndrome in a patient w

Hemolytic-Uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha

✍ Daniel Schlaifer; Philippe Dumazer; Nathalie Spenatto; Madeleine Mignon-Conte; P 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 2 views

Interferon alfa-2c in chronic myelogenou

Interferon alfa-2c in chronic myelogenous leukemia (CML): Hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma

✍ Herrmann, F. ;Jonas, D. ;Helfrich, S. G. ;Lindemann, A. ;Schleiermacher, E. ;Mer 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 849 KB

A phase I/II study of recombinant interf

A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia

✍ Anger, B. ;Porzsolt, F. ;Leichtle, R. ;Heinze, B. ;Bartram, C. ;Heimpel, H. 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 337 KB

Simultaneous homoharringtonine and inter

Simultaneous homoharringtonine and interferon-α in the treatment of patients with chronic-phase chronic myelogenous leukemia

✍ Susan O'Brien; Moshe Talpaz; Jorge Cortes; Jianqin Shan; Francis J. Giles; Stefa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Intensive chemotherapy induction followe

Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

✍ Hagop M. Kantarjian; Moshe Talpaz; Michael J. Keating; Elihu H. Estey; Susan O'b 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

In a pilot study, 32 patients with Philadelphia chromosome-positive chronic myelogenous leukemia were treated with intensive chemotherapy induction followed by interferon-alpha (IFN-A) maintenance. Intensive chemotherapy consisted of three cycles of daunorubicin 120 mg/mz on day 1, cytarabine 80 mg/

Divergent in vivo and in vitro antileuke

Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia

✍ W. E. Aulitzky; C. Peschel; D. Desprès; J. Aman; P. Trautman; H. Tilg; G. Rudolf 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 754 KB